These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 15507091

  • 1. Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.
    Elsner J, Escher SE, Forssmann U.
    Allergy; 2004 Dec; 59(12):1243-58. PubMed ID: 15507091
    [Abstract] [Full Text] [Related]

  • 2. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y.
    J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
    [Abstract] [Full Text] [Related]

  • 3. Recent developments in CCR3 antagonists.
    De Lucca GV.
    Curr Opin Drug Discov Devel; 2006 Jul; 9(4):516-24. PubMed ID: 16889234
    [Abstract] [Full Text] [Related]

  • 4. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J, Rieder S, Escher S, Eilers B, Forssmann WG, Elsner J, Forssmann U.
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [Abstract] [Full Text] [Related]

  • 5. A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
    Suzuki K, Morokata T, Morihira K, Sato I, Takizawa S, Kaneko M, Takahashi K, Shimizu Y.
    Eur J Pharmacol; 2007 Jun 01; 563(1-3):224-32. PubMed ID: 17336292
    [Abstract] [Full Text] [Related]

  • 6. Identification and characterization of novel antagonists of the CCR3 receptor.
    Warrior U, McKeegan EM, Rottinghaus SM, Garcia L, Traphagen L, Grayson G, Komater V, McNally T, Helfrich R, Harris RR, Bell RL, Burns DJ.
    J Biomol Screen; 2003 Jun 01; 8(3):324-31. PubMed ID: 12857386
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High level expression, activation, and antagonism of CC chemokine receptors CCR2 and CCR3 in Chinese hamster ovary cells.
    Parody TR, Stone MJ.
    Cytokine; 2004 Jul 07; 27(1):38-46. PubMed ID: 15207250
    [Abstract] [Full Text] [Related]

  • 12. Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications.
    Amerio P, Frezzolini A, Feliciani C, Verdolini R, Teofoli P, De Pità O, Puddu P.
    Curr Drug Targets Inflamm Allergy; 2003 Mar 07; 2(1):81-94. PubMed ID: 14561178
    [Abstract] [Full Text] [Related]

  • 13. Selective inhibition of eosinophil influx into the lung by small molecule CC chemokine receptor 3 antagonists in mouse models of allergic inflammation.
    Das AM, Vaddi KG, Solomon KA, Krauthauser C, Jiang X, McIntyre KW, Yang XX, Wadman E, Welch P, Covington M, Graden D, Yeleswaram K, Trzaskos JM, Newton RC, Mandlekar S, Ko SS, Carter PH, Davies P.
    J Pharmacol Exp Ther; 2006 Jul 07; 318(1):411-7. PubMed ID: 16614169
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG, Houghton GC, Roderick J, Santella JB, Wacker DA, Welch PK, Orlovsky YI, Wadman EA, Trzaskos JM, Davies P, Decicco CP, Carter PH.
    Bioorg Med Chem Lett; 2005 Feb 01; 15(3):787-91. PubMed ID: 15664858
    [Abstract] [Full Text] [Related]

  • 17. n-Nonanoyl-CCL14 (NNY-CCL14), a novel inhibitor of allergic airway inflammation is a partial agonist of human CCR2.
    Gupta S, Erdmann G, Schulz-Maronde S, Escher SE, Richter R, Forssmann WG, Elsner J, Forssmann U.
    Allergy; 2008 Oct 01; 63(10):1317-23. PubMed ID: 18782110
    [Abstract] [Full Text] [Related]

  • 18. Eotaxin receptor (CCR3) antagonism in asthma and allergic disease.
    Erin EM, Williams TJ, Barnes PJ, Hansel TT.
    Curr Drug Targets Inflamm Allergy; 2002 Jun 01; 1(2):201-14. PubMed ID: 14561201
    [Abstract] [Full Text] [Related]

  • 19. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
    El-Shazly A, Ishikawa T.
    Mediators Inflamm; 1999 Jun 01; 8(3):177-9. PubMed ID: 10704057
    [Abstract] [Full Text] [Related]

  • 20. Responses of leukocytes to chemokines in whole blood and their antagonism by novel CC-chemokine receptor 3 antagonists.
    Bryan SA, Jose PJ, Topping JR, Wilhelm R, Soderberg C, Kertesz D, Barnes PJ, Williams TJ, Hansel TT, Sabroe I.
    Am J Respir Crit Care Med; 2002 Jun 15; 165(12):1602-9. PubMed ID: 12070060
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.